






| Group | Defining Distinction | Formulation Decision |
|---|---|---|
| EAAs | All nine essential members | Specify which members are included and their quantities. |
| BCAAs | Branched-chain amino acids: leucine, isoleucine, and valine | Define the three-component ratio and its calculation basis. |
| Nonessential amino acids | Normally synthesized by the body | Select individual molecules against the formulation objective. |
| Conditionally essential | Synthesis may be insufficient under certain conditions | Evaluate the relevant ingredient individually. |



| Illustrative Ingredient | Selection Question |
|---|---|
| L-Glutamine | What stability evidence applies to the proposed aqueous process and storage? |
| L-Arginine | Is the requested material the free form or a separately specified salt? |
| Glycine | How will its sensory contribution affect the complete formula? |
| L-Tyrosine | Will dissolution be adequate at the intended concentration and pH? |
| L-Leucine | How will particle characteristics affect wetting and distribution during mixing? |


| Illustrative Example | Chemical Relationship | Purchasing Check |
|---|---|---|
| N-Acetyl-L-Cysteine | Acetylated derivative. | Measure the derivative separately from its parent molecule. |
| L-Lysine Hydrochloride | Salt form. | Clarify whether content describes the salt or free-form component. |
| Glutathione | Tripeptide. | Confirm the specified peptide and relevant form. |
| Finished Product | Practical Evaluation |
|---|---|
| Dry blends and sachets | Check component distribution after mixing, transfer, and filling; particle differences can create segregation. |
| Capsules and tablets | Assess fill-weight consistency, flow, and compression behavior where applicable. |
| Nutritional mixtures | Confirm individual component content and the agreed ratio throughout the batch. |
| Beverages | Test dissolution, taste, precipitation, and retained content through processing and storage. |


| Specification Area | Evidence to Review |
|---|---|
| Identity and configuration | Identity testing and relevant L-form verification; total assay alone does not establish stereochemical composition. |
| Content calculation | As-is or dry-basis reporting, salt composition, hydration state, and component-level results where relevant. |
| Impurities and contaminants | Material-specific limits for related substances, processing residues, elemental contaminants, and microbiology, with appropriate methods. |
| Physical behavior | Particle distribution, moisture, density, and application-relevant dissolution information. |
| Batch and storage records | Lot-linked Certificate of Analysis, packaging, storage instructions, and supported shelf-life information. |

Raw ingredients are manufacturing inputs. Finished supplements contain a completed formulation in a defined dosage form, with its own labeling and product requirements. A raw material’s qualification does not establish finished product suitability.
No. A ratio leaves content, ingredient forms, calculation basis, excipients, and uniformity unresolved. Specify ingredient mass or free-form equivalents as the calculation basis, and list every component in the purchasing specification.
No. Glycine is achiral and has no L or D enantiomer designation. Where stereochemistry applies, specify the required form and verification; a total-content result alone does not resolve configuration.
Dispersibility does not establish complete dissolution. Suspended particles may settle after mixing stops. Evaluate clarity, sedimentation, taste, and retained content under actual drink processing and storage conditions before approving the material.
A dry-basis assay expresses content after correction for the specified drying or water measurement. Compare results using the same reporting basis and method, particularly when moisture or water of hydration affects interpretation.
Not automatically. Counterions and any water of hydration contribute to material weight, so equal masses may deliver different quantities of the required component. Calculate from documented composition, then validate the revised formulation before substitution.